Recombinant follicle stimulating hormone vs urinary‐derived gonadotrophins
Clinical pregnancy rate · ovulation induction in polycystic ovarian syndrome
Recombinant follicle stimulating hormone showed no clear difference in clinical pregnancy rate per woman compared with urinary‐derived gonadotrophins (low certainty).
1 finding from 1 review
- Gonadotrophins for ovulation induction in women with polycystic ovary syndrome 2019 · Cochrane Headline outcomes onlyRR 1.05 [0.88, 1.27]8 studies · 1330 participantsLow